Complete Genomics, Inc. (GNOM) Posts Narrower than Expected Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts GNOM Hot Sheet
Join SI Premium – FREE
Complete Genomics, Inc. (NASDAQ: GNOM) reported Q1 EPS of ($0.48), $0.04 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $6.8 million versus the consensus estimate of $5.46 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Helen of Troy (HELE) Tops Q2 EPS by 28c, Misses on Revenue; Offers FY27 Guidance
- Resources Connection (RGP) Misses Q1 EPS by 14c
- Oil-Dri Corp. (ODC) Reports Q4 EPS of $1.00
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
